$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
吃尼洛替尼多久可以见效?
2025-10-19 11:44:20
Check Details
尼洛替尼中国上市价格
2025-10-19 11:44:20
Check Details
尼洛替尼国内买的到吗?
2025-10-19 11:44:20
Check Details
尼洛替尼是哪个国家的?
2025-10-19 11:44:20
Check Details
帕纳替尼有药吗?
2025-10-19 11:44:20
Check Details
帕纳替尼是否纳入医保?
2025-10-19 11:44:20
Check Details
帕纳替尼需要吃多久?
2025-10-19 11:44:20
Check Details
吃帕纳替尼可以活多久?
2025-10-19 11:44:20
Check Details
帕纳替尼治疗白血病有效果吗?
2025-10-19 11:44:20
Check Details
帕纳替尼对白血病的效果
2025-10-19 11:44:20
Check Details
米哚妥林的适应症有哪些
2025-10-19 11:44:20
Check Details
米哚妥林的用法与用量
2025-10-19 11:44:20
Check Details
1
2
...
450
451
452
453
454
455
456
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
2
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
3
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
4
A Key Therapeutic Breakthrough Against T315I-Mutant CML
5
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
6
Tafasitamab and Lenalidomide Combination Therapy Guide
7
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
8
Gilteritinib Professional Medication Guide & Dosage Management
9
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies
10
Clinical Application and Safety Monitoring of Revumenib (Menin Inhibitor) in Acute Leukemia
11
Ixazomib & Pomalidomide in Multiple Myeloma: Mechanisms & Clinical Insights
12
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation